Carbenoxolone does not cause a syndrome of mineralocorticoid excess in sheep

Steroids

Volumn 63, Issue 2, 1998, Pages 99-104

  Dodic, Miodrag ^a   May, C N ^a   Coghlan, J P ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

11 hydroxysteroid dehydrogenase; Carbenoxolone; Cortisol; Mineralocorticoid receptor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; MINERALOCORTICOID RECEPTOR;

ALDOSTERONE RELEASE; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; ENZYME INHIBITION; HORMONE RECEPTOR INTERACTION; HYDROCORTISONE RELEASE; NONHUMAN; SHEEP;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; CARBENOXOLONE; ENZYME INHIBITORS; FEMALE; HALF-LIFE; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; METABOLIC CLEARANCE RATE; MINERALOCORTICOIDS; POTASSIUM; SALIVA; SHEEP; SODIUM;

EID: 0032005459     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(97)00141-4     Document Type: Article

References (37)

1. 1. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987). Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275.
2. 2. Seckl JR (1993), 11β-Hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. Eur J Clin Invest 23:589-601.
3. 3. Monder C (1991). Corticosteroids, receptors, and the organ-specific functions of 11β-hydroxysteroid dehydrogenase. FASEB J 5:3047-3054.
4. 4. Lombes M, Kenouch S, Souque A, Farman N, Rafestin-Oblin ME (1994). The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 135:834-840.
5. 5. Jausons-Loffreda N, Chabaret C, Pons M (1994). Role of the A/B region of the human mineralocorticoid receptor in aldosterone response selectivity. Biochem Biophys Res Commun 205:1610-1616.
6. 6. Lakshmi V, Monder C (1988). Purification and characterization of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology 123: 2390-2398.
7. 7. Agarwal A, Monder C, Eckstein B, White P (1989). Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 264:18939-18943.
8. 8. Roland BL, Krozowski ZS, Funder JW (1995). Glucocorticoid receptor, mineralocorticoid receptors, 11β-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Mol Cell Endocrinol 111:R1-R7.
9. 9. Tannin GM, Agarwal AK, Monder C, New MI, White PC (1991). The human gene for 11β-hydroxysteroid dehydrogenase. J Biol Chem 266:16653-16658.
10. 10. Stewart PM, Murry BA, Mason JI (1994). Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity nicotineamide adenin dinucleotid-dependent enzyme and differs from the cloned type I isoform. J Clin Endocrinol Metab 79:480-434.
11. 11. Yang K, Smith CL, Dales D, Hammond GL, Challis JRG (1992). Cloning of an ovine 11β-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. Endocrinology 131:2120-2126.
12. 12. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS (1994). Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type II enzyme. Mol Cell Endocrinol 105:R11-R17.
13. 13. Zhou MY, Gomez-Sanchez EP, Cox DI, Cosby D, Gomez-Sanchez CE (1995). Cloning, expression and tissue distribution of the rat nicotinamid adenin dinucleotid-dependent 11β-hydroxysteroid dehydrogenase. Endocrinology 136:3729-3734.
14. 14. Cole TJ (1995). Cloning of the mouse 11β-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 136:4693-4696.
15. +-dependent isoform of 11β-hydroxysteroid dehydrogenase. J Biol Chem 269:25959-25962.
16. 16. Campbell DM, Yu M, Yang K (1996). Ovine 11β-hydroxysteroid dehydrogenase type 2 gene predicts a protein distinct from that deduced by the cloned kidney cDNA at the C-terminus. Mol Cell Endocrinol 119:113-118.
17. 17. Krozowski Z, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK (1995). Immunohistochemical localisation of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 80:2203-2209.
18. 18. Wilson RC, Krozowski ZC, Li K, Obeyesekere VR, Rallaghy-Alar M, Harbison MD, Wei JQ, Shackleton CHL, Funder JW, New MI (1995). A mutation in the HSD 11B2 gene in a family with apperent mineralocorticoid excess. J Clin Endocrinol Metab 80:2263-2265.
19. 19. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC (1995). Human hypertension caused by mutations in the kidney isoenzyme of 11β-hydroxysteroid dehydrogenase. Nat Gen 10:394-399.
20. 20. Edwards CRW, Walker BR, Benediktsson R, Seckl JR (1993). Congenital and acquired syndromes of apparent mineralocorticoid excess. J Steroid Biochem Mol Biol 45:1-5.
21. 21. Stewart PM, Wallace AM, Atherden SM, Shearing CH, Edwards CRW (1990). Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11β-hydroxysteroid dehydrogenase activity in man. Clin Sci 87:49-54.
22. +-dependent 11β-hydroxysteroid dehydrogenase (11β-HSD3). Steroids 62:444-450.
23. 23. Funder J, Myles K (1996). Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: In vivo binding studies. Endocrinology 137: 5264-5268.
24. 24. Denton DA (1957). The study of the sheep with permanent unilateral parotid fistulae. Quarterly J Exp Physiol 42:72-95.
25. + depletion. J Physiol (Lond.) 140:129-147.
26. 26. Zehr JE, Johnson JA, Moore WW (1969). Left atrial pressure, plasma osmolality, and ADH levels in the unanesthetized ewe. Am J Physiol 217:1672-1680.
27. 27. Coghlan JP, Wintour M, Scoggins BA (1966). The measurement of corticosteroids in adrenal vein blood of sheep. Aust J Exp Biol Med Sci 44:639-664.
28. 28. Tait JF (1963). Review: The use of isotopic steroids for the measurement of production rates in vivo. J Clin Endocrinol 26:1285-1297.
29. 3H-aldosterone in the plasma of normal subjects. J Clin Invest 40:72-80.
30. 30. Whithworth JA (1994). Haemodynainic and metabolic effects of CBX in normal subjects and patients with renal impairment. Clin Exp Hypertens [A] 16:431-450.
31. 31. Morris JD, Souness GW (1990). The 11β-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone. Am J Physiol 258:F756-F759.
32. 32. Whitworth JA, Coghlan JP, Denton DA, Graham WF, Humphrey TJ, Scoggins BA (1979). Comparison of the effects of 'glucocorticoid' and 'mineralocorticoid' infusions on blood pressure in sheep. Clin Exper Hypertens [A] 1(5):649-663.
33. 33. Yang K, Yu M (1994). Evidence for distinct isoforms of 11β-hydroxysteroid dehydrogenase in the ovine liver and kidney. J Steroid Biochem Mol Biol 49:245-250.
34. 34. Brown RW, Chapman KE, Kotelevstev Y, Yau JL, Lindsay RS, Brett L, Leckie C, Murad P, Lyons V, Mullins JJ, Edwards CR, Seckl JR (1996). Cloning and production of antisera to human placental 11β-hydroxysteroid dehydrogenase type 2. Biochem J 313:1007-1017.
35. 35. Leckie C, Chapman KE, Edwards CR, Seckl JR (1995). LLC-PKI cells model 11β-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors. Endocrinology 136:5561-5569.
36. 36. Buhler H, Perschel FH, Fitzer R, Hierholzer K (1994). Endogenous inhibitors of 11β-HSD: Existence and possible significance. Steroids 59:131-135.
37. 37. Soro A, Panarelli M, Holloway CD, Fraser R, Kenyon CJ (1997). In vivo and in vitro effects of carbenoxolone on glucocorticoid receptor binding and glucocorticoid activity. Steroids 62:388-394.